Hormone therapy clinics carry a stricter compliance bar than injectables-only medspas, and the medical director you pick determines whether you can legally prescribe testosterone, estrogen, and peptide protocols at all in 2026.
- A medical director for hormone therapy clinics must sign off on testosterone and peptide protocols, not just Botox — verify scope first.
- Collaborating physician agreements cover NP and PA prescribing authority for hormone therapy in 2026 — Buy this first.
- Good faith exams before treatment starts are the top audit finding in medspa chart reviews — Buy, do not skip.
- Chart review catches missing lab documentation before a state board does — Consider it a standing add-on.
- Bulk oversight packages without state-specific licensure checks are a Skip for multi-state hormone clinics.
Why this matters
Hormone therapy sits in a different regulatory lane than filler and Botox. Testosterone is a controlled substance in most states, and prescribing it without a physician tied to the chart is the fastest way to draw a board complaint. Medical director services for medspas exist specifically to close that gap for aesthetic professionals who are not physicians themselves.
Regulations differ across all 50 states, and hormone protocols usually carry a monitoring cadence — bloodwork every 90 days is standard practice for testosterone patients — that a generic medical director contract may not account for. A director who only understands injectables will miss what a hormone clinic actually needs signed off. That gap is where clinics get flagged in 2026, not from bad injection technique but from missing documentation.
Who this is for
This guide is for nurse practitioners, physician assistants, and aesthetic nurses running or launching a hormone therapy clinic — testosterone replacement, bioidentical hormone pellets, peptide therapy — who need a physician of record to legally prescribe and document treatment. It's also for medspa owners adding hormone services to an existing injectables practice and hitting a licensure wall they didn't expect.
What to look for in a medical director for hormone therapy clinics
State-matched licensure
Your collaborating physician has to hold an active license in the state where you're treating patients, not just a license somewhere. Hormone therapy rules vary by state, and a mismatch here voids the entire arrangement no matter how good the paperwork looks otherwise.
Prescribing scope that actually covers hormones
Many aesthetic medical director contracts are written around neurotoxins and dermal filler. Confirm in writing that testosterone, estrogen, and peptide prescribing sit inside the agreement — this is the single most common gap clinics find after signing.
Good faith exam completion before treatment starts
A good faith exam establishes the physician relationship before the first prescription goes out, and it's the first thing a board audit checks. Skipping it or treating it as a formality is the most avoidable compliance mistake in hormone therapy.
Chart review cadence
Hormone therapy generates ongoing documentation — lab panels, dosage adjustments, follow-up notes — that needs periodic review, not a one-time sign-off. Quarterly chart review catches missing labs before they become a pattern a board can flag.
Response time for consults
Dosage questions and lab result reviews come up constantly in hormone therapy, and a director who takes days to respond slows patient care and creates a documentation lag. Ask what a typical turnaround looks like before you sign anything.
Multi-state flexibility
If you run patients in more than one state, or plan to, confirm the arrangement can extend without starting from scratch. Growing clinics waste real time re-negotiating oversight state by state when this isn't addressed upfront.
Get hormone therapy oversight sorted
Match with a collaborating physician licensed for your state and scope.
Top picks
Collaborating physician agreement for NPs and PAs — the backbone pick. This covers the actual prescribing authority hormone clinics need to operate legally, and it's the arrangement most state boards check for first. Collaborating physician agreements for nurse practitioners spell out scope, so testosterone and peptide prescribing are named explicitly, not assumed. One spec that matters: the agreement should name the specific therapies covered, not a generic "aesthetic services" clause. Verdict: Buy.
Good faith exams — the exam requirement you can't skip. A pre-treatment exam establishes the physician-patient relationship on record before any hormone prescription is written. Good faith exams for medspas get logged before treatment starts, which is exactly what a board audit looks for first. One number that matters: exams need to happen before the first prescription, not retroactively. Verdict: Buy.
Chart review — the audit trail. Hormone therapy produces a running record of lab panels and dosage changes, and periodic review catches missing documentation before it piles up. Chart review services for medspas work best on a quarterly cadence for clinics running active testosterone or pellet programs. Verdict: Consider as a standing add-on alongside your collaborating physician agreement.
Medical director oversight for nurse injectors — the general layer. This covers broader protocol sign-off across aesthetic services, useful if your clinic runs hormone therapy alongside injectables and skin treatments. It's less specific to hormone prescribing than a dedicated collaborating physician agreement, so confirm scope before treating it as sufficient on its own. Verdict: Consider as a complement, not a substitute.
Collaborating physician for aesthetic nurses — the broad-scope option. Built for nurses handling a wide range of aesthetic services, this arrangement can work for hormone clinics that also run injectables, but hormone-specific prescribing needs to be confirmed line by line. Clinics that assume broad coverage automatically includes hormone therapy get surprised at audit time. Verdict: Consider, with scope verified in writing.
What to avoid
- Bulk discount packages with no state-specific licensure check — the price looks good until you realize your collaborating physician isn't licensed where you're treating patients.
- Telehealth-only oversight with no good faith exam — several states still require an in-person or synchronous exam before hormone therapy starts, and skipping it invalidates the whole arrangement.
- General aesthetic medical directors who don't ask about labs — if a director never asks what monitoring a testosterone protocol requires, they're not equipped to sign off on it.
“If your collaborating physician can’t tell you which labs a testosterone protocol requires, they’re not qualified to sign off on it.”
Verdict comparison table
| Service | Prescribing scope | State coverage | Documentation | Verdict |
|---|---|---|---|---|
| Collaborating physician agreement (NP/PA) | Full hormone prescribing | State-matched | Named agreement | Buy |
| Good faith exams | Pre-treatment clearance | Per-state cadence | Exam record on file | Buy |
| Chart review | Documentation only | Cross-state | Full audit trail | Consider |
| Medical director oversight (general) | Broad aesthetic scope | Single-state focus | Protocol sign-off | Consider |
| Bulk discount-only packages | Unclear | Not state-verified | Minimal | Skip |
FAQ
What does a medical director do for a hormone therapy clinic?
A medical director for hormone therapy clinics reviews and signs off on treatment protocols, oversees prescribing, and provides the physician relationship required to legally administer testosterone, estrogen, or peptide therapy. In 2026, this role also typically includes periodic chart review to keep documentation audit-ready.
Do nurse practitioners need a collaborating physician to prescribe testosterone?
In most states, yes — NPs prescribing testosterone or other hormone therapies need a documented collaborating physician agreement naming that scope specifically. A general aesthetic oversight contract that only covers Botox and filler usually does not extend to hormone prescribing.
What is a good faith exam and is it required before hormone therapy?
A good faith exam establishes the physician-patient relationship on record before treatment begins, and it is required in many states before the first hormone prescription is written. Skipping it is one of the most common findings in medspa chart audits.
Can one medical director oversee hormone therapy clinics in multiple states?
Only if that physician holds an active license in each state where patients are treated — licensure does not automatically transfer. Clinics expanding to new states need to confirm coverage extends before treating patients there.
How much does a medical director cost for a hormone therapy clinic?
Cost varies by state, scope, and how many services are bundled, so it’s worth getting a direct quote rather than assuming a flat rate. Bulk purchasing options can lower per-provider cost for medspas onboarding several nurses or injectors at once.
What’s the difference between a medical director and a collaborating physician?
A medical director typically oversees protocols and clinic-wide compliance, while a collaborating physician is named in a specific prescribing agreement with an individual NP or PA. Hormone therapy clinics usually need both roles covered, sometimes by the same physician.
How often should chart review happen for hormone therapy patients?
Quarterly chart review is a common standard for clinics running active testosterone or pellet programs, since lab panels and dosage adjustments accumulate fast. Waiting longer than that risks missing gaps before a board audit finds them.
Is telehealth-only medical oversight enough for hormone therapy clinics?
Usually not on its own — most states still require an in-person or synchronous good faith exam before hormone therapy starts, regardless of how oversight is structured afterward. Confirm your state’s specific rule before relying on telehealth alone.
One last thing
The clinics that get flagged in 2026 audits almost never get flagged for the hormone protocol itself — they get flagged for a good faith exam that happened after the first prescription instead of before it. Fix the order of operations before you worry about anything else on this list.
Related guides
